BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T110000
DTEND;TZID=America/Los_Angeles:20260910T120000
DTSTAMP:20260812T085808Z
CREATED:20260805T181605Z
LAST-MODIFIED:20260812T085808Z
UID:10941-1789038000-1789041600@thebiocalendar.com
SUMMARY:Scaling Next-Gen MSC Therapies Without Scaling Risk
DESCRIPTION:Mesenchymal stromal cell (MSC) therapies are entering a pivotal stage of development. As more programs move toward late-stage clinical trials and commercialization\, developers must produce enough high-quality cells to meet growing demand while maintaining potency\, consistency\, and manufacturability. How can companies scale MSC production without compromising the biological properties that drive therapeutic efficacy? \nJoin Cell & Gene’s Chief Editor\, Erin Harris\, for this Cell & Gene Live discussion featuring Miguel Forte\, M.D.\, Ph.D.\, CEO of Kiji Therapeutics\, Silviu Itescu\, M.D.\, Founder\, CEO\, and Managing Director of Mesoblast\, and Edward Ahn\, Ph.D.\, CEO of MEDIPOST. Together\, these experts bring decades of experience developing\, manufacturing\, and commercializing MSC therapies. Their combined expertise spans early innovation\, scalable manufacturing\, and commercial execution. \nThe expert panel will discuss strategies for scaling MSC therapies while minimizing donor variability\, preserving potency\, improving process consistency\, and building commercially viable manufacturing platforms. They will also examine advances in cell sourcing\, process development\, quality systems\, and manufacturing strategy. Attendees will leave with practical insights into what developers should prioritize today to improve their products’ chances of clinical and commercial success. \nRegistration is free.
URL:https://thebiocalendar.com/event/scaling-next-gen-msc-therapies-without-scaling-risk/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/26_09_CGL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T110000
DTEND;TZID=America/Los_Angeles:20260910T120000
DTSTAMP:20260817T231840Z
CREATED:20260813T125211Z
LAST-MODIFIED:20260817T231840Z
UID:11060-1789038000-1789041600@thebiocalendar.com
SUMMARY:Autonomous Impinging Jet Mixing for LNP Process Development
DESCRIPTION:Lipid nanoparticles (LNPs) are critical to the delivery of genetic medicines\, but developing scalable\, reproducible manufacturing processes remains complex and resource-intensive. Because LNP quality can be highly sensitive to formulation and processing conditions\, identifying the right parameters efficiently is essential. \nThis webinar will explore how impinging jet mixing\, automation\, inline analytics\, and data-driven optimization can accelerate LNP process development. Attendees will see how automated design of experiments\, dynamic process sweeps\, self-optimization\, and predictive modeling can help map process-property relationships and identify conditions that achieve target quality attributes.
URL:https://thebiocalendar.com/event/autonomous-impinging-jet-mixing-for-lnp-process-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-10-26-Knauer-eBlast-700x200-1.png
END:VEVENT
END:VCALENDAR